OTC : USAQ
$0 (0.0%)
OTC
Troy James Grogan
Medical - Devices
Healthcare
USAQ
12
US
USD
0.00
1.82
1.79
0.84
0.06
$2.69M
1.74
3.37
-48.98
-0.01
$0.02
$457.42K
17.37%
17.37%
51.21%
27.09%
7.38
0.03
0.03
3/5
0 Analysts
%
6.74
5/9
$251.05K
$1.89M
$368K
$612.49K
$5.03M
1.81
7.35
1.68
91.63%
2.96%
8.23%
0.52%
$0.26
-47 days
| Name | Title |
|---|---|
| Olivia Giamanco | Marketing Director |
| Troy James Grogan | Chief Executive Officer, Chief Financial Officer, President & Chairman |
| Cyndi Cole | Financial Controller |
No votes yet today — be the first to share your view!
About QHSLab, Inc. (OTC:USAQ) Stock
QHSLab, Inc. is a company operating in the medical technology and Software-as-a-Service (SaaS) sectors. Its core focus is on advancing value-based healthcare, medical informatics, and personalized medicine driven by algorithms. The firm also develops digital therapeutic solutions and on-site technologies intended for remote patient oversight, the management of chronic conditions, and proactive health maintenance. Among its offerings is a proprietary cloud-based SaaS platform, also known as QHSLab (Quality Health Score Lab expert system). This system empowers physicians and healthcare organizations to securely record and store electronic patient data. Additionally, QHSLab, Inc. acts as a distributor, providing primary care physicians with AllergiEnd, a product line encompassing diagnostic t ... ools and allergen immunotherapy treatments. All of its solutions are strategically designed to aid in the prevention, early identification, effective management, and potential reversal of chronic diseases. The company was established in 1983 and is headquartered in West Palm Beach, Florida. It operated under the name USA Equities Corp. until April 2022, when it officially rebranded to QHSLab, Inc. The company also maintains a strategic partnership with Medical License Factory, LLC.
QHSLab (OTCQB:USAQ) Reports Second Quarter and First Half 2026 Unaudited Financial Results
2026-08-03 08:30:00
Integrated Service Program (ISP) Revenue More Than Doubles Year-over-Year as Gross Margins Expand and Financing Costs Decline
Frequently Asked Questions
What is the current QHSLab, Inc. (USAQ) stock price?
QHSLab, Inc.(OTC:USAQ) stock price is $0.35 in the last trading session. During the trading session, USAQ stock reached the peak price of $1.136 while $0.08 was the lowest point it dropped to. The percentage change in USAQ stock occurred in the recent session was 0.0% while the dollar amount for the price change in USAQ stock was $0.
USAQ's industry and sector of operation?
The OTC listed USAQ is part of Medical - Devices industry that operates in the broader Healthcare sector.
Who are the executives of USAQ?
Olivia Giamanco
| Marketing Director
Troy James Grogan
| Chief Executive Officer, Chief Financial Officer, President & Chairman
Cyndi Cole
| Financial Controller
|
|
How many employees does USAQ have?
Number of USAQ employees currently stands at 12. USAQ operates from 901 Northpoint Parkway, West Palm Beach, FL 33407, US.
Link for USAQ official website?
Official Website of USAQ is: https://www.qhslab.com
How do I contact USAQ?
USAQ could be contacted at phone #929 379 6503 and can also be accessed through its website. USAQ operates from 901 Northpoint Parkway, West Palm Beach, FL 33407, US.
How many shares of USAQ are traded daily?
The average number of USAQ shares traded daily for last 3 months was 6.87K.
What is the market cap of USAQ currently?
The market value of USAQ currently stands at $5.26M with its latest stock price at $0.35